Invitation to presentation of Electrolux Group Q1 report

2025-04-17 Electrolux Group HaiPress

STOCKHOLM,April 15,2025 -- On 29thof April,Electrolux Group will publish the results for the first quarter of 2025,at approx. 07.00 CET.

Media,investors and analysts are invited to a simultaneous video webcast and telephone conference on the same day following the release of the results,starting at 09.00 CET where Yannick Fierling,President and CEO,together with Therese Friberg,CFO,will present the report.

Information on how to join the video webcast and telephone conference is available HERE.

Slides used in the presentation and report will be available at the Group's website,www.electroluxgroup.com/ir.

For more information:


Ann-Sofi Jönsson,Head of Investor Relations & Sustainability Reporting,+46 73 035 1005


Maria Åkerhielm,Investor Relations Manager,+46 70 796 3856


Electrolux Group Press Hotline,+46 8 657 65 07

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/electrolux-group/r/invitation-to-presentation-of-electrolux-group-q1-report,c4135466

The following files are available for download:

https://mb.cision.com/Main/1853/4135466/3387875.pdf

250415 Invitation Q1 2025

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

2The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

6MEXC Claims Dual Wins at BeInCrypto 100 Awards as Best Centralized Exchange and Best Exchange in LATAM

MEXC Claims Dual Wins at BeInCrypto 100 Awards as Best Centralized Exchange and Best Exchange in LATAM

©copyright 2009-2020 Singapore Info Map